Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Breast Neoplasms 251Neoplasms 175Prostatic Neoplasms 146Colorectal Neoplasms 108Lung Neoplasms 99Leukemia, Myeloid, Acute 77Pancreatic Neoplasms 76Carcinoma, Non-Small-Cell Lung 69Multiple Myeloma 67Brain Neoplasms 65Melanoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Ovarian Neoplasms 53Glioblastoma 50Head and Neck Neoplasms 49Uterine Cervical Neoplasms 48Neoplasm Metastasis 48Carcinoma, Hepatocellular 48Recurrence 41Sarcoma 39Hematologic Neoplasms 39Glioma 39Endometrial Neoplasms 37Carcinoma, Renal Cell 37Squamous Cell Carcinoma of Head and Neck 36Lymphoma, Non-Hodgkin 36Stomach Neoplasms 35Rectal Neoplasms 35Lymphoma 34Leukemia 34

Interventions

pimonidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Immune System Diseases × 30 days × Clear all
NCT04658303 2026-06-11

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

University of Pittsburgh

Recruiting
20 enrolled
Dermatologic

Immune System Diseases, Melanoma

NCT02663297 2026-06-09

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
18 enrolled 10 charts
Lymphoid

Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT04996706 2026-05-26

LEO

Mayo Clinic

Enrolling by invitation
21,000 enrolled
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡